Has Manish Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $784,635 in general payments to Manish Patel, MD across 293 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Manish Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Manish Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Manish Patel, MD

Orthopaedic Surgery · Franklin, VANPI 1851389852

Payments from drug & device makers

What this record shows

The money is spread across several categories — royalties or licence payments (57.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Ortho Development Corporation accounts for 96.1% of it on its own, with 26 other manufacturers making up the rest. 2025 is the largest year on record at $321,939, more than ten times the $8,422 reported in 2019. Among orthopaedic surgery clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$784,635in general payments, 2019–2025

Across 293 payments — averaging $2677.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Ortho Development Corporation$754K
Medical Device Business Services, Inc.$21K
Johnson & Johnson$2K
Medacta USA, Inc.$2K
Advita Ortho, LLC$1K
Sanara Medtech Inc.$843
plus $3K from 21 others

$55,917in research payments, 2019–2025

Across 2 payments — averaging $27,958 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Medical Device Business Services, Inc.$56K

What the payments were for

Royalty or licence$451,08257%
Consulting fees$310,67740%
Speaking & faculty fees$5850%
Travel & lodging$9,7231%
Food & beverage$12,5682%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Ortho Development Corporation	141	$754,133
Medical Device Business Services, Inc.	19	$21,403
Johnson & Johnson	57	$2,292
Medacta USA, Inc.	8	$1,876
Advita Ortho, LLC	2	$1,000
Sanara Medtech Inc.	3	$843
Zimmer Biomet	9	$502
Heraeus Medical, LLC.	7	$384
Stryker	6	$363
Corentec America Inc	1	$328
Pacira Pharmaceuticals Incorporated	2	$203
UOC USA Inc	2	$190
Nalu Medical, Inc.	1	$147
Smith+Nephew	4	$127
Orthalign Inc	1	$120
Bioventus LLC	4	$119
Daiichi Sankyo Inc.	6	$116
Heron Therapeutics, Inc.	2	$86
Ferring Pharmaceuticals Inc.	5	$86
AbbVie	2	$66
Electronic Waveform Lab, Inc.	2	$63
Davol Inc.	2	$56
Baxter Healthcare	3	$47
Coloplast	1	$29
Pacira Therapeutics, Inc.	1	$26
Genentech USA, Inc.	1	$15
Sanofi-aventis U.S. LLC	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

BKS TriMax$352,878
Balanced Knee System$176,550
ATTUNE$20,112
Balance Knee Revision System$2,951
GMK SPHERE$1,255
TRULIANT$1,000
CellerateRx$843
ACTIS$699
Balanced Knee Revision System$574
PRIMARY SHOULDER$405
Corentec$328
PALACOS$212
Entrada Hip Stem$149
Nalu Neurostimulation System$147
Persona$139
MAKO$123
ORTHALIGN PLUS$120
UTS, Conformity, U-MII, U2 Revision Stem, PSA, USTAR, U2 Knee$113
EXPAREL$111

How this compares

$784,635 in reported general payments places this provider in the 95th percentile of 473 orthopaedic surgery providers in Virginia.

See all orthopaedic surgery providers in Virginia →

Medicare billing

Part B allowed, 2024

$885,146

Medicare patients

1,242

Services billed

7,894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Diclofenac Sodium	30	$1,711
Cephalexin	263	$670
Ondansetron OdtOndansetron	59	$574
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen	73	$505
Methylprednisolone	44	$304
Clindamycin Hcl	57	$133
Hydromorphone Hcl	17	$88

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Franklin

Dale YoungNorth Chesterfield$10.9M
James DowdVirginia Beach$6.1M
Mark de BloisNorth Chesterfield$4M
Cato LaurencinCharlottesville$3.5M
Randall PeytonSterling$2.9M
William MihalkoCharlottesville$2M
David MillerNorth Chesterfield$1.7M
Keith LawhornFairfax$1.6M
Joseph GonduskyVirginia Beach$1.2M
Joshua HerzogNorth Chesterfield$1M

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →